Your browser is no longer supported. Please, upgrade your browser.
Settings
STIM [NASD]
Neuronetics, Inc.
Index- P/E- EPS (ttm)-1.68 Insider Own5.60% Shs Outstand18.89M Perf Week-14.11%
Market Cap372.59M Forward P/E- EPS next Y-0.78 Insider Trans-6.20% Shs Float15.06M Perf Month-14.75%
Income-31.40M PEG- EPS next Q-0.24 Inst Own57.90% Short Float3.34% Perf Quarter77.87%
Sales51.00M P/S7.31 EPS this Y41.30% Inst Trans2.18% Short Ratio1.08 Perf Half Y178.85%
Book/sh1.45 P/B10.37 EPS next Y48.30% ROA-36.10% Target Price22.75 Perf Year411.22%
Cash/sh2.05 P/C7.35 EPS next 5Y- ROE-88.80% 52W Range1.25 - 22.43 Perf YTD35.28%
Dividend- P/FCF- EPS past 5Y- ROI-34.00% 52W High-31.52% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin76.50% 52W Low1128.80% ATR2.06
Employees122 Current Ratio1.40 Sales Q/Q-22.50% Oper. Margin-54.00% RSI (14)45.01 Volatility12.56% 10.72%
OptionableYes Debt/Eq1.25 EPS Q/Q51.20% Profit Margin-61.40% Rel Volume0.84 Prev Close15.03
ShortableYes LT Debt/Eq0.00 EarningsMar 02 BMO Payout- Avg Volume467.98K Price15.36
Recom1.40 SMA20-10.91% SMA502.21% SMA200114.06% Volume209,077 Change2.20%
Jan-22-21Upgrade William Blair Mkt Perform → Outperform
Feb-06-20Initiated BTIG Research Buy $11
Jul-24-18Initiated Canaccord Genuity Buy
Mar-03-21 08:00AM  
04:00AM  
Mar-02-21 08:55AM  
07:57AM  
07:30AM  
06:30AM  
04:50AM  
Mar-01-21 10:12AM  
Feb-23-21 08:00AM  
Feb-16-21 07:00AM  
Feb-11-21 08:00AM  
Feb-10-21 07:00AM  
Feb-02-21 04:05PM  
Jan-28-21 10:30PM  
04:01PM  
Jan-19-21 08:00AM  
Jan-14-21 05:06AM  
Jan-12-21 04:05PM  
Jan-11-21 12:29PM  
Jan-07-21 04:30PM  
08:00AM  
Dec-14-20 09:55PM  
Dec-08-20 04:05PM  
Nov-30-20 04:05PM  
07:23AM  
Nov-23-20 04:05PM  
Nov-12-20 04:05PM  
Nov-02-20 06:15PM  
04:05PM  
02:30PM  
Oct-26-20 12:31PM  
Oct-19-20 04:05PM  
Oct-15-20 10:59AM  
Oct-13-20 08:00AM  
Oct-05-20 08:00AM  
Oct-01-20 08:00AM  
Sep-29-20 08:00AM  
Sep-22-20 08:00AM  
Aug-31-20 11:04AM  
Aug-04-20 08:45AM  
07:30AM  
Jul-28-20 12:33PM  
Jul-21-20 08:00AM  
Jul-17-20 04:05PM  
08:57AM  
Jul-14-20 04:15PM  
Jun-26-20 07:00AM  
Jun-10-20 01:01PM  
Jun-04-20 04:30PM  
Jun-03-20 09:53AM  
May-12-20 05:21PM  
May-07-20 08:00AM  
May-05-20 07:30AM  
06:00AM  
Apr-21-20 08:00AM  
Apr-09-20 02:35PM  
07:52AM  
Apr-08-20 04:11PM  
04:10PM  
09:44AM  
Mar-30-20 07:30AM  
Mar-16-20 07:30AM  
Mar-13-20 01:18PM  
Mar-06-20 10:15AM  
08:49AM  
07:30AM  
Mar-05-20 12:54PM  
Mar-03-20 07:30AM  
06:00AM  
Feb-25-20 12:30PM  
Feb-18-20 08:00AM  
Feb-13-20 07:00AM  
Feb-12-20 04:05PM  
Jan-21-20 07:30AM  
Jan-16-20 10:14AM  
Dec-20-19 05:47PM  
Nov-25-19 07:30AM  
Nov-21-19 08:00AM  
Nov-07-19 07:30AM  
Nov-05-19 08:45AM  
07:30AM  
Nov-01-19 07:30AM  
Oct-30-19 01:53PM  
Oct-29-19 10:33AM  
Oct-28-19 07:30AM  
Oct-22-19 07:30AM  
Oct-21-19 07:30AM  
Oct-03-19 07:30AM  
Oct-01-19 07:30AM  
Sep-04-19 07:30AM  
Aug-27-19 01:15PM  
Aug-19-19 07:30AM  
Aug-07-19 09:24PM  
Aug-06-19 08:45AM  
07:30AM  
Aug-01-19 07:30AM  
Jul-29-19 07:30AM  
Jul-25-19 04:30PM  
Jul-23-19 08:00AM  
Jul-17-19 04:19PM  
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrist customers. Neuronetics, Inc. was founded in 2003 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sullivan Keith JPresident and CEOFeb 05Sale17.9645,632819,551681,539Feb 09 06:10 PM
Sullivan Keith JPresident and CEOJan 26Sale18.8322,829429,870602,171Jan 28 09:42 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryJan 22Sale21.2812,696270,171188,453Jan 25 09:26 PM
Harper GregoryVP of Prod. Dev. & OperationsJan 21Sale18.212,96954,065150,993Jan 25 09:27 PM
Furlong StephenCFOJan 21Sale18.217,585138,123261,316Jan 25 09:26 PM
Farley Brian EDirectorMar 13Buy2.2840,00091,200217,606Mar 16 04:49 PM
Guthrie DanielChief Commercial OfficerMar 12Buy2.365,00011,800146,855Mar 13 04:26 PM
Farley Brian EDirectorMar 12Buy2.1810,00021,800177,606Mar 16 04:49 PM
Furlong StephenVP and CFOMar 10Buy2.0025,00050,000274,184Mar 11 05:31 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryMar 10Buy2.005,00010,000182,399Mar 11 05:28 PM
Thatcher ChristopherPresident and CEOMar 04Option Exercise0.8720,00017,400249,811Mar 04 08:16 PM